Overview

Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]

Status:
Completed
Trial end date:
2007-01-05
Target enrollment:
Participant gender:
Summary
This is a two period study of healthy adult subjects to characterize the effect of the dosing of ketoconazole on the the way the body reacts to a dose of GW679769, and to assess the safety profile of oral casopitant with and without ketoconazole. This study will consist of a screening period, two treatment periods and a post-treatment follow-up visit.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Casopitant
Ketoconazole